Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III multicentric study of sirolimus in refractory complex vascular anomalies
2015-001703-32Phase 3Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of sirolimus in vascular abnormality, sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Statistical efficacy of sirolimus. Started Oct 2015; status: completed.
02
Drugs
sirolimus
03
Conditions
vascular abnormality
Beyond the preview
Go deeper on 2015-001703-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001703-32.